Close Menu

A discussion is going on over at the DrugMonkey blog on the materials and methods sections of papers. "This stupid failure to actually publish the real methodology (yes, including how many times the prep failed before you lucked onto the one that worked and really don't know why!) wastes my taxpayer dollars," he writes, adding that page restrictions are a "lame excuse" for not publishing the real methodology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.